Insys $250M Opioid Penalty for Quality Fraud Bill Thompson Feb 27, 2023 Daily, Damages, Health, Law, Medical Bills, News, Patient Safety, Pharma, Products, Quality Fraud, Regulation Comments Off on Insys $250M Opioid Penalty for Quality Fraud Link to the DOJ announcement below: FOR IMMEDIATE RELEASE Wednesday, June 5, 2019 Opioid Manufacturer Insys Therapeutics Agrees to Enter $225 Million Global Resolution of Criminal and Civil Investigations
